Progesterone Inhibits Human Myometrial Contractions by Action on Membrane Receptors
Abstract
Background: The mechanisms for myometrial inhibition are still being investigated Aim: To examine mechanisms of progesterone (P4) inhibition of uterine contractility. Methods: Prospective study Tertiary care center at St. Joseph"s Hospital and at Maricopa Hospital, Phoenix, AZ and research center in Arizona, USA. During 2010-2011, 24 women given birth by cesarean section. Uterine tissues from women (n=24) at term were suspended in organ chambers and exposed to various agents. Contractility was registered and compared before and after addition of agents. Tissues were treated with P4 alone, a progestin (R5020) with low affinity to the progesterone membrane receptor (mPR), or a non-sex steroid (cholesterol). Other tissues were pretreated with inhibitors of adenylate cyclase (SQ 22536), phosphodiesterase (rolipram), nitric oxide (NO) synthases (L-NAME) or a nuclear P4 receptor antagonist (mifepristone, MIF), followed by P4. Data were analyzed by ANOVA. Results: P4 (P0.05) inhibitory effects. P4 inhibition is not blocked by MIF, SQ, ODQ, rolipram or L-NAME (P>0.05). Conclusions: P4 rapidly inhibits myometrial contractility by nongenomic mechanisms through action on mPR but not via cAMP, cGMP, or NO
Keywords
References
- Fsapo A. Force of labour. In: Iffy L, Kaminetzky HA, editors. Principles and Practice of Obstetrics and Perinatology. John Wiley and Sons, Inc. 1981; 7617
- Chwalisz K, Hegele-Hartung C, Schulz R, Shi SQ, Louton PT. Progesterone control of cervical ripening - experimental studies with the progesterone antagonists onapristone, lilopristone and mifepristone. In: Leppert P, Woessner F, editors. The Extracellular Matrix of the Uterus, Cervix and Fetal Membranes: Synthesis, Degradation and Hormonal Regulation. Perinatology Press. 1991; 119-131.
- Chwalisz K, Garfield RE. Regulation of the uterus and cervix during pregnancy and labor. Ann NY Acad Sci. 1997; 828: 238-53.
- Hegele-Hartung C, Chwalisz K, Beier HM, Elger W. Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist Onapristone (Zk-98.299) - an electron-microscopic study. Hum Reprod. 1989; 4: 369-77.
- Johnson JW, Austin KL, Jones GS, Davis GH, and King TM. Efficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med. 1975; 293: 675-80.
- Yemini M, Borenstein R, Dreazen E. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate in the prevention of premature labor. Am J Obstet Gynaecol. 1985; 151: 574-77.
- Harrikainen-Sorri AL, Kauppila, A, Tuimala, R. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynaecol. 1980; 56: 692-95.
- Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol. 1990; 97: 149-54.
- Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Eng J Med. 2003; 348: 2379-85. da Fonseca EB, Bittar RE, Carvalho MHB, Zugaib
- M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynaecol. 2003; 188: 419-24.
